Loading…
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents
The novel tetracyclic compounds, synthesized as bioisosters of fluoroquinolones, exhibited potent activity against bacteria and cancer cell lines, together with absence of cytotoxicity against normal cells. A facile synthesis of model 4-oxopyrido[3′,2′:4,5]thieno[3,2- b]indole-3-carboxylic acids 9a–...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2011-04, Vol.19 (8), p.2541-2548 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The novel tetracyclic compounds, synthesized as bioisosters of fluoroquinolones, exhibited potent activity against bacteria and cancer cell lines, together with absence of cytotoxicity against normal cells.
A facile synthesis of model 4-oxopyrido[3′,2′:4,5]thieno[3,2-
b]indole-3-carboxylic acids
9a–
e was achieved via Stille arylation of 2-chloro-3-nitro-4-oxothieno[2,3-
b]pyridine-5-carboxylate and a subsequent microwave-assisted phosphite-mediated Cadogan reaction. The new compounds were tested for their in vitro antimicrobial and antiproliferative activity. Compounds
9a–
c and
9e exhibited very high potency against Gram positive
Bacillus subtilis and
Bacillus megaterium at concentrations 0.000015–0.007
μg/mL. They also displayed excellent activity towards other Gram positive bacilli and staphylococci and Gram negative
Haemophilus influenzae, being in most cases superior or equal to commercial fluoroquinolones. Both
9a and
9c were inhibitors of the DNA gyrase activity. As concerns antitumor properties, compounds
9b–
e showed growth inhibition of MCF-7 breast tumor and A549 non-small cell lung cancer cells with IC
50 1.6–2.8
μM and 2.6–6.9
μM, respectively, coupled with absence of cytotoxicity towards normal cells. These compounds are promising as dual acting chemotherapeutics. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2011.03.018 |